Otenaproxesul
id:
otenaproxesul-309-15421078
title:
Otenaproxesul
text:
Otenaproxesul is a analgesic and anti-inflammatory drug being developed by Antibe Therapeutics. An NSAID structurally derived from naproxen, in 2016 it received approval to commence phase II clinical trials as a treatment for osteoarthritis after completing phase I clinical trials in 2015.
In 2018, the drug completed trials for gastrointestinal safety, and in 2020 completed phase IIb trials on efficacy of pain reduction. Initial phase III clinical trials in 2021 failed to meet the necessary crit
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Otenaproxesul
date created:
date modified:
2024-01-11T10:11:25Z
main entity:
{"identifier":"Q27255936","url":"https://www.wikidata.org/entity/Q27255936"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/c/cb/Otenaproxesul_skeletal.svg","width":1199,"height":435}
fields total:
13
integrity:
15